Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection
- 1 September 2007
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 88 (9) , 2513-2519
- https://doi.org/10.1099/vir.0.82974-0
Abstract
Patients with inherited bleeding disorders who received clotting factor concentrates before 1987 have high rates of hepatitis C virus (HCV) or HCV/human immunodeficiency virus (HIV) infection. To determine whether the persistent nature of HIV affects the genetic diversity of HCV by less selective pressure through the immunosuppression of HIV/HCV-coinfected patients, both the change of genetic diversity and selective pressure were examined in the HCV envelope genes (E1 and E2) of 325 genotype 1a subclones from eight HIV-positive and five HIV-negative patients with two time points (more than 6 years apart). To infer the genetic diversity of HCV in each patient, we used two approaches. One method was to estimate the difference of total evolutionary distances in the phylogenetic tree between the two time points, and another was to estimate the changes of genetic diversity along the time based on the coalescence theory. The two results indicate that the HIV-positive group has significantly more diverse population structure than the HIV-negative group. A comparative analysis of the synonymous and non-synonymous substitutions found that the HIV-positive group was subject to less selective pressure than the HIV-negative group. In conclusion, HIV-positive patients would have a more diversified HCV population than HIV-negative patients due to less selective pressure from the immune system.Keywords
This publication has 29 references indexed in Scilit:
- Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis CAIDS, 2004
- Hepatitis C Virus (HCV) Diversity in HIV‐HCV–Coinfected Subjects Initiating Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2004
- Impact of Highly Active Antiretroviral Therapy and Immunologic Status on Hepatitis C Virus Quasispecies Diversity in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsJournal of Virology, 2003
- Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcomeProceedings of the National Academy of Sciences, 2002
- Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐AnalysisClinical Infectious Diseases, 2001
- Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral QuasispeciesScience, 2000
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 1999
- Long-term evolution of the 5'UTR and a region of NS4 containing a CTL epitope of hepatitis C virus in two haemophilic patients.Journal of General Virology, 1997
- Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort StudyBlood, 1994